Vascular dementia patients taking ARICEPT show significant treatment benefits in cognition and function

ARICEPT efficacy and safety study in new treatment area presented at the Second International Congress on Vascular Dementia

Salzburg, Austria - Treatment with ARICEPT (donepezil hydrochloride tablets) significantly improved the cognitive and global (overall) function of patients with vascular dementia (VaD), compared with placebo, according to results from a first-of-its-kind clinical study presented today at the Second International Congress on Vascular Dementia (ICVD) in Salzburg, Austria. Only patients with VaD were included in this study. Patients with a diagnosis of Alzheimers disease (AD) were excluded. ARICEPT is currently indicated for the treatment of mild to moderate AD.

VaD, cognitive decline caused by a single, localized stroke, or series of strokes, is second only to AD as a cause of dementia. Up to one-third of all diagnosed dementia cases are VaD. In Europe, the prevalence of VaD is estimated to be 1.5 to 4.8 percent for people 70 to 80 years of age; of the patients over 65 years old diagnosed with dementia in the United States, approximately 9 to 39 percent have VaD.

This study is one of two conducted to examine the efficacy and safety of ARICEPT in patients with VaD, excluding patients diagnosed with AD. The results of the second study are expected to be released in mid 2002. Eisai, which discovered and developed ARICEPT, will work with its strategic alliance partner, Pfizer Inc., to file both studies with regulatory authorities worldwide for an indication to treat VaD.

"This groundbreaking study is the first time a cholinesterase inhibitor has been studied in a population composed primarily of patients with vascular dementia. VaD is a condition that has been underdiagnosed and undertreated," said Raymond D. Pratt, M.D., senior director, clinical research, Eisai Inc., who presented the data at the Second International Congress on Vascular Dementia. These results suggest ARICEPT may be a p

Contact: Melissa Furrie
Porter Novelli

Page: 1 2 3 4

Related medicine news :

1. Hebrew University one of 25 institutions involved in new European Vascular Genomics Network
2. No magic pill for treating dementia symptoms
3. Cardiovascular risk factors in midlife strongly linked to risk of dementia
4. Moderate alcohol intake may reduce risk of dementia in older women
5. Weight loss may be an early sign of dementia in the elderly
6. Reduced risk of institutionalisation in patients with dementia
7. Going through the motions to better treat dementia
8. Major overhaul needed in end-of life care for patients with dementia
9. Major overhaul needed in end-of life care for patients with dementia
10. Key immune system protein reduced in HIV-associated dementia patients
11. Researchers identify novel method of distinguishing Alzheimers disease from other types of dementia

Post Your Comments:

(Date:4/5/2020)... ... April 05, 2020 , ... In the midst of crisis, ... Nufabrx®, a proprietary biomaterial company that seamlessly embeds active ingredients including vitamins, supplements ... has shifted production for a new line of reusable copper medical masks called ...
(Date:4/2/2020)... ANNANDALE, Va. (PRWEB) , ... April 02, 2020 , ... ... exceptional gift of $1 million from donor Debra Coffman Howe of Palm Beach, Florida. ... support for NOVA nursing students. Supporting NOVA nursing is more important than ever ...
(Date:4/1/2020)... , ... April 02, 2020 , ... Medical Device Change ... EDT, https://www.fdanews.com/mdchangemanagement , What change management method should one be using ... is often dependent on the type of change. Is it due to post-market design ...
(Date:4/1/2020)... ... April 01, 2020 , ... Global mobile data platform provider Zerion ... adjusting to new needs based on COVID-19. , As cases continue to rise across ... types. , Zerion will extend support by offering free basic iFormBuilder accounts and forms ...
(Date:3/28/2020)... ... 27, 2020 , ... Suntuity AirWorks ( https://suntuityairworks.com ), the ... their drone equipment and training personnel to help towns and cities combat the ... and Agras drones, Suntuity AirWorks is mobilizing their drone equipment and services divisions ...
Breaking Medicine News(10 mins):
(Date:4/2/2020)... (PRWEB) , ... April 02, 2020 , ... NCPDP has ... at the Meeting of the NCPDP Board of Trustees on Wednesday, May 6, 2020. ... Pooja Babbrah, M.B.A., PBM Practice Lead, Point-of-Care Partners, newly elected to the Board of ...
(Date:4/1/2020)... ... April 01, 2020 , ... ... is continuing her partnership with the esteemed Haute Beauty network. , The Haute ... present Dr. Green as a leading Anti-Aging Expert. , Haute Beauty offers a ...
(Date:3/30/2020)... ... March 30, 2020 , ... Energage, the leader in helping ... a series of survey question packs that enable organizations to keep the lines ... As the current situation continues to evolve, The Energage Operational Readiness Survey Packs ...
Breaking Medicine Technology:
Cached News: